IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Amanta Healthcare Ltd.
Issue Open Date 01-Sep-25  
Issue Closing Date 03-Sep-25  
Application Money 100  
Allotment Money  
Price Band 120 - 126  
Minimium Application No. 119  
Issue Size (Shares) 7000000  
Market Lot 1.00  
Objective
1. Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat;2. Funding capital expenditure requirements towards purchase of equipment, plant and machinery for setting up new manufacturing line for Small Volume Parenteral (“SVP”) at Hariyala, Kheda, Gujarat; and3. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1500000   314135486   209.42  
Qualified Institutional Buyers   2000000   71722490   35.86  
Retail Individual Investors   3500000   192422762   54.98  
Business Description
We are a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterileliquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal (“ABFS”)and Injection Strech Blow Moulding (“ISBM”
more...
Promoter's Holding
Total Share Capital   17738828  
Offered to Public   10000000  
Promoter's Holding (Pre-Issue)   61.53  
Promoter's Holding (Post-Issue)    
Address
8th Floor
Shaligram Corporates
C. J. Marg
Ambli
Ahmedabad ,
Gujarat ,
380058
Phone: 079-67777600
Email: cs@amanta.co.in
Website: www.amanta.co.in
Registrar
MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
Beeline Capital Advisors Pvt Ltd.
Promoters
Bhavesh Patel
Jayshreeben Patel
Jitendrakumar Patel
Milcent Appliances Pvt Ltd.
Vishal Patel
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.